Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Villalobos

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
AJR. American Journal of Roentgenology|August 3, 2022
REBOA: Expanding Applications From Traumatic Hemorrhage to Obstetrics and Cardiopulmonary Resuscitation, From the <i>AJR</i> Special Series on Emergency RadiologyLinzi A Webster, Olivia Little, Alexander Villalobos, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular CarcinomaAlexander Villalobos, Howard Hussein Dabbous, Olivia Little, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 1, 2021
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CTAlexander Villalobos, Bernard Cheng, William Wagstaff, et al.
Journal of Gastrointestinal Cancer|November 27, 2025
Radioembolization in Hepatocellular Carcinoma: Indications and OutcomesBahareh Gholami, Ali Afrasiabi, Paolo Varela, et al.
Cardiovascular and Interventional Radiology|July 27, 2021
Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular CarcinomaMohammad Elsayed, William Wagstaff, Keywan Behbahani, et al.
Clinical Nuclear Medicine|June 11, 2024
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm StudyNima Kokabi, Linzi A Webster, Howard Dabbous, et al.
Canadian Journal of Gastroenterology & Hepatology|August 2, 2021
Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular CarcinomaAlexander Villalobos, William Wagstaff, Mian Guo, et al.
Cardiovascular and Interventional Radiology|May 12, 2026
Comparative Analysis of the LOBO Device and Coils for Proximal Splenic Artery Embolization: A Multi-Institutional Retrospective StudyRoshan Valentine, Massoud Allahyari, Johannes L du Pisane, et al.
Cardiovascular and Interventional Radiology|November 24, 2020
Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched StudyLinzi Arndt, Alexander Villalobos, William Wagstaff, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
AJR. American Journal of Roentgenology|August 3, 2022
REBOA: Expanding Applications From Traumatic Hemorrhage to Obstetrics and Cardiopulmonary Resuscitation, From the <i>AJR</i> Special Series on Emergency RadiologyLinzi A Webster, Olivia Little, Alexander Villalobos, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular CarcinomaAlexander Villalobos, Howard Hussein Dabbous, Olivia Little, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 1, 2021
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CTAlexander Villalobos, Bernard Cheng, William Wagstaff, et al.
Journal of Gastrointestinal Cancer|November 27, 2025
Radioembolization in Hepatocellular Carcinoma: Indications and OutcomesBahareh Gholami, Ali Afrasiabi, Paolo Varela, et al.
Cardiovascular and Interventional Radiology|July 27, 2021
Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular CarcinomaMohammad Elsayed, William Wagstaff, Keywan Behbahani, et al.
Clinical Nuclear Medicine|June 11, 2024
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm StudyNima Kokabi, Linzi A Webster, Howard Dabbous, et al.
Canadian Journal of Gastroenterology & Hepatology|August 2, 2021
Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular CarcinomaAlexander Villalobos, William Wagstaff, Mian Guo, et al.
Cardiovascular and Interventional Radiology|May 12, 2026
Comparative Analysis of the LOBO Device and Coils for Proximal Splenic Artery Embolization: A Multi-Institutional Retrospective StudyRoshan Valentine, Massoud Allahyari, Johannes L du Pisane, et al.
Cardiovascular and Interventional Radiology|November 24, 2020
Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched StudyLinzi Arndt, Alexander Villalobos, William Wagstaff, et al.
Pageof 2